Zocor Leads to Chemical Injury in Patient’s Muscles

The FDA warned consumers and the medical community this week about the risk of muscle damage and rhabdomyolysis from highest doses of the cholesterol drug simvastatin. In June 2011, the FDA issued a warning to doctors about potential side effects of Zocor when used at high doses (80 mg), saying that the cholesterol drug may increase the risk of muscle injury or myopathy. The warning came after more than a year of FDA experts reviewing clinical trials on Zocor and other drugs containing simvastatin, which had been available to the manufacturers for some time. Zocor muscle injury side effects

80mg Zocor Linked to Liver Damage In FDA Warning

Statin drugs have been linked to diabetes and muscle injury in many recent studies. European researchers report that high-dose regimens of a class of drugs known as statins, such as Zocor may be linked to the onset of diabetes in rare cases, although the drugs do lower the risk of cardiovascular disease. The results of the study were published online in June by the Journal of the American Medical Association. Zocor has also been linked to muscle injury and Zocor liver damage. The researchers looked at five studies involving a total of 32,752 subjects. All were given statin-based cholesterol drugs, but half were given high doses of about 80 mg per day and the other half were given lower doses of 20 to 40 mg per day for an average of about five years. They found that more participants given high doses developed diabetes than those who were given lower doses.  Patients taking 80mg dose Zocor are more likey to experience myopothy, or Zocor rhabdomyolysis as well.

Highest Dose of Zocor Banned By FDA Due To Muscle Damage

In June 2011, the FDA issued a warning to doctors about potential side effects of Zocor when used at high doses (80 mg), saying that the cholesterol drug may increase the risk of Zocor muscle injury or myopathy. The warning came after more than a year of FDA experts reviewing clinical trials on Zocor and other drugs containing simvastatin, which had been available to the manufacturers for some time.  The FDA warns that the 80 mg dose of Zocor carries an increased risk of muscle injury,

80mg Dose of Zocor Now Comes With Strong Warning of Muscle Damage

With a long history of increased risk for Zocor muscle injury, the drug's label has recently been amended by the FDA. The FDA’s new recommendation was prompted by a seven-year study and patient reports that prove those taking the higher dosage of simvastatin have a greater risk of muscle injury and other Zocor side effects than patients treated with lower doses or other statins. The new restrictions and warnings also apply to Vytorin and Simcor, which are combination medications that include

FDA Warns Of Deadly Link to Rare Muscle Syndrome with Zocor

People taking the highest approved doses of the cholesterol-lowering drug Zocor (simvastatin) may be at increased risk for muscle injuries, the U.S. Food and Drug Administration (FDA) warned earlier this year. The Zocor drug safety communication also contains a list of drugs that should not be used in combination with Zocor, including the combination cholesterol drugs Vytorin and Simcor. The FDA began reviewing the side effects of Zocor in March 2010, when it first warned of the possible increased risk of rhabdomyolysis and other muscle injuries. The FDA estimates that 2.1 million people were prescribed some drug containing simvastin in 2010. Eleven patients who used 80 milligrams of the statin drug per day developed Zocor rhabdomyolysis compared to none among those

Could Zocor Liver Damage Lead to Lawsuits?

The statin drug Zocor has been used in many patients to treat high levels of cholesterol, which can lead to serious, life-threatening conditions like heart disease and stroke. It has helped many patients regain a balance in their life and reduced the risk of these serious conditions in several cases, but it also has been linked to a barrage of Zocor side effects that have been plaguing patients since the drug was first released. Diabetes has been associated with statin use, as has a serious muscle condition called Guillian-Barre Syndrome, which has manifested in patients but has not yet been clinically proven to be linked to Zocor use. However, muscle injury is the most prominent and most prevalent side effect, with possibility of progression of Zocor rhabdomyolysis, that users have complained of.

Zocor Lawsuits More Muscle Injury than Other Side Effects

Zocor is a popular medication that is prescribed to patients at risk of heart disease. It is a statin drug, which has proven effective in managing high cholesterol levels in patients for whom cholesterol levels are a problem or a contributing factor to heart disease. Zocor and other statin medications have been a great deal of help to a significant number of at-risk patients, but for others, side effects of the Zocor statin medication have been a detriment to their health.

Zocor has been linked to many serious muscle conditions, including rhabdomyolysis and myopathy. Zocor myopathy is a muscle condition that involves the deterioration of muscle tissue, leading to muscle weakness or injury, and in severe cases can manifest as Zocor rhabdomyolysis, in which